Yuval Cohen
2017
In 2017, Yuval Cohen earned a total compensation of $3.2M as Chief Executive Officer at Corbus Pharmaceuticals Holdings, a 58% increase compared to previous year.
Compensation breakdown
| Bonus | $267,383 |
|---|---|
| Option Awards | $2,511,886 |
| Salary | $463,000 |
| Total | $3,242,269 |
Cohen received $2.5M in option awards, accounting for 77% of the total pay in 2017.
Cohen also received $267.4K in bonus and $463K in salary.
Rankings
In 2017, Yuval Cohen's compensation ranked 3,298th out of 14,666 executives tracked by ExecPay. In other words, Cohen earned more than 77.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,298 out of 14,666 | 78th |
Division Manufacturing | 1,132 out of 5,772 | 80th |
Major group Chemicals And Allied Products | 310 out of 2,075 | 85th |
Industry group Drugs | 238 out of 1,731 | 86th |
Industry Pharmaceutical Preparations | 188 out of 1,333 | 86th |
Source: SEC filing on April 13, 2018.
Cohen's colleagues
We found three more compensation records of executives who worked with Yuval Cohen at Corbus Pharmaceuticals Holdings in 2017.